Craneware plc (LON:CRW)‘s stock had its “buy” rating reissued by research analysts at Peel Hunt in a report released on Friday. They presently have a GBX 1,450 ($18.44) price target on the stock. Peel Hunt’s price target points to a potential upside of 13.06% from the company’s current price.

Craneware plc (LON CRW) remained flat at GBX 1282.50 during trading on Friday. 290 shares of the stock were exchanged. The stock’s 50 day moving average is GBX 1,276.95 and its 200 day moving average is GBX 1,250.96. The firm’s market capitalization is GBX 345.74 million. Craneware plc has a 52 week low of GBX 783.00 and a 52 week high of GBX 1,885.00.

ILLEGAL ACTIVITY WARNING: This news story was first reported by American Banking News and is owned by of American Banking News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of US and international trademark & copyright law. The correct version of this news story can be accessed at

Craneware plc Company Profile

Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.

Receive News & Ratings for Craneware plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware plc and related companies with's FREE daily email newsletter.